SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Science and innovation: the US pharmaceutical industry during the 1980s
0 references·16 citing·54 second hopsampled
Science and innovation: the US pharmaceutical industry during the 1980s (1995)Science and innovation: the US pharmaceut…Direct and cross scheme effects in a research and development subsidy program (2017)Direct and cross scheme effec…The evolution of the pharmaceutical industry (2015)The evolution of the pharmace…The Pharmaceutical Industry (2013)The Pharmaceutical IndustryTechnological development at the boundaries of the firm: a knowledge‐based examination in drug development (2012)Technological development at …Innovation and Firm Growth: Is R&D Worth It? (2012)Innovation and Firm Growth: I…The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry (2011)The impact of public basic re…Organizational and Institutional Genesis: The Emergence of High-Tech Clusters in the Life Sciences (2010)Organizational and Institutio…Contractibility and the Design of Research Agreements (2010)Contractibility and the Desig…Networks and Institutions (2008)Networks and InstitutionsExperience and scale and scope economies: trade‐offs and performance in development (2006)Experience and scale and scop…The influence of institutional factors on the technology acquisition performance of high-tech firms: survey results from Germany and Japan (2004)The influence of institutiona…North Atlantic Innovative Relations of Swiss Pharmaceuticals and the Proximities with Regional Biotech Arenas (2004)North Atlantic Innovative Rel…DO FIRMS CHANGE CAPABILITIES BY HIRING NEW PEOPLE? A STUDY OF THE ADOPTION OF SCIENCE-BASED DRUG DISCOVERY (2004)DO FIRMS CHANGE CAPABILITIES …Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D (2000)Economies of Scale in Experim…Economies of scale in experimentation: knowledge and technology in pharmaceutical R&D (2000)Economies of scale in experim…Do Scientists Pay to Be Scientists? (1999)Do Scientists Pay to Be Scien…The Theory of the Growth of the Firm (1995)Econometric Analysis of Cross Section and Panel Data (2001)Alternative research strategies in the knowledge movement: From macro bias to micro‐foundations and multi‐level explanation (2009)Learning by hiring and change to organizational knowledge: Countering obsolescence as organizations age (2015)American Economic Review (2019)Innovation in the 21st Century: Architectural Change, Purpose, and the Challenges of Our Time (2020)Economic Welfare and the Allocation of Resources for Invention (1962)An Evolutionary Theory of Economic Change. (1983)Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy (1986)Documenting the financialisation of the pharmaceutical industry (2020)Innovation in pharmaceutical R&D: mapping the research landscape (2020)A dynamic multi-sector analysis of technological catch-up: The impact of technology cycle times, knowledge base complexity and variety (2021)Endogenous Technological Change (1989)The price of innovation: new estimates of drug development costs (2003)Handbook of Economic Growth (2005)Does Public Scientific Research Complement Private Investment in Research and Development in the Pharmaceutical Industry? (2007)Why it pays off to pay us well: The impact of basic research on economic growth and welfare (2016)Identifying the influence of natural disasters on technological innovation (2021)Technological paradigms and technological trajectories (1982)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Creating Silicon Valley in Europe (2007)Big Pharma, little science? (2012)Implications of AI innovation on economic growth: a panel data study (2023)An evolutionary theory of economic change (1982)An Evolutionary Theory of Economic Change (1983)Towards a Geography of Knowledge Creation: The Ambivalences between ‘Knowledge as an Object’ and ‘Knowing in Practice’ (2007)Entrepreneurial Geographies: Support Networks in Three High-Technology Industries (2009)On the Role and Interrelationship of Spatial, Social and Cognitive Proximity: Personal Knowledge Relationships of R&D Workers in the Cambridge Information Technology Cluster (2011)Innovation and Learning: The Two Faces of R & D (1989)The Role of Human Capital in Lowering the Barriers to Engaging in Innovation: Evidence from the Spanish Innovation Survey (2014)Persistence of innovation and patterns of firm growth (2019)The impact of high-speed rail on innovation: An empirical test of the companion innovation hypothesis of transportation improvement with China’s manufacturing firms (2019)The Strength of Weak Ties (1973)Economic Action and Social Structure: The Problem of Embeddedness (1985)Bowling alone: the collapse and revival of American community (2000)SME internationalization modes in the German biotechnology industry: The influence of imitation, network position, and international experience (2015)Why do policies change? Institutions, interests, ideas and networks in three cases of policy reform (2016)Internationalization barriers of SMEs from developing countries: a review and research agenda (2020)Endogenous Growth Theory (1999)R&D Subsidies as Dual Signals in Technological Collaborations (2019)Start-up subsidies: Does the policy instrument matter? (2019)Public support for innovation: A systematic review of the literature and implications for open innovation (2020)Industrial Market Structure and Economic Performance. (1971)Appropriating the Returns from Industrial Research and Development (1987)Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)Managed Care or Managed Inequality? A Call for Critiques of Market‐Based Medicine (2002)Post-TRIPS Options for Access to Patented Medicines in Developing Nations (2002)Pharmaceutical pricing policies in a global market (2008)Moral Hazard and Observability (1979)The Costs and Benefits of Ownership: A Theory of Vertical and Lateral Integration (1986)Multitask Principal–Agent Analyses: Incentive Contracts, Asset Ownership, and Job Design (1991)Different Missions and Commitment Power in R&D Organizations: Theory and Evidence on Industry-University Alliances (2008)Licensing Contracts: Control Rights, Options, and Timing (2016)The Effect of Mortgage Securitization on Foreclosure and Modification (2016)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

No references inside the corpus for this window.

Cited by

  • 2008Networks and Institutions244 cited
  • 2011The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry213 cited
  • 2013The Pharmaceutical Industry196 cited
  • 2015The evolution of the pharmaceutical industry177 cited
  • 2010Contractibility and the Design of Research Agreements172 cited
  • 2012Innovation and Firm Growth: Is R&D Worth It?165 cited
  • 2017Direct and cross scheme effects in a research and development subsidy program160 cited
  • 2000Economies of scale in experimentation: knowledge and technology in pharmaceutical R&D144 cited
  • 2004DO FIRMS CHANGE CAPABILITIES BY HIRING NEW PEOPLE? A STUDY OF THE ADOPTION OF SCIENCE-BASED DRUG DISCOVERY139 cited
  • 2004North Atlantic Innovative Relations of Swiss Pharmaceuticals and the Proximities with Regional Biotech Arenas128 cited
  • 2006Experience and scale and scope economies: trade‐offs and performance in development126 cited
  • 1999Do Scientists Pay to Be Scientists?124 cited
  • 2000Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D120 cited
  • 2012Technological development at the boundaries of the firm: a knowledge‐based examination in drug development

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

108 cited
  • 2004The influence of institutional factors on the technology acquisition performance of high-tech firms: survey results from Germany and Japan99 cited
  • 2010Organizational and Institutional Genesis: The Emergence of High-Tech Clusters in the Life Sciences93 cited